Profit forecast: We slightly adjusted the company's EPS for 2012-2014 to 0.98, 0.56, and 0.79 to maintain the company's “gain” rating, taking into account the space in the national market for health essences. Risk Warning: Price increases and national promotion of Guhan Health Essence fell short of expectations
【华泰证券】紫光古汉:养生精稳步增长,下半年值得期待
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated